Single-Cell Radiotracer Allocation via Immunomagnetic Sorting to Disentangle PET Signals at Cellular Resolution.
Where this comes from
- Record sourced from PubMed, PMID 35589403.
- Also identified by DOI 10.2967/jnumed.122.264171 and PMC identifier 9536696.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
With great interest, our independent groups of scientists located in Korea and Germany recognized the use of a very similar methodologic approach to quantify the uptake of radioactive glucose (<sup>18</sup>F-FDG) at the cellular level. The focus of our investigations was to disentangle microglial <sup>18</sup>F-FDG uptake. To do so, CD11b immunomagnetic cell sorting was applied to isolate microglia cells after in vivo <sup>18</sup>F-FDG injection, to allow simple quantification via a γ-counter. Importantly, this technique reveals a snapshot of cellular glucose uptake in living mice at the time of injection since <sup>18</sup>F-FDG is trapped by hexokinase phosphorylation without a further opportunity to be metabolized. Both studies indicated high <sup>18</sup>F-FDG uptake of single CD11b-positive microglia cells and a significant increase in microglial <sup>18</sup>F-FDG uptake when this cell type is activated in the presence of amyloid pathology. Furthermore, another study noticed that immunomagnetic cell sorting after tracer injection facilitated determination of high <sup>18</sup>F-FDG uptake in myeloid cells in a range of tumor models. Here, we aim to discuss the rationale for single-cell radiotracer allocation via immunomagnetic cell sorting (scRadiotracing) by providing examples of promising applications of this innovative technology in neuroscience, oncology, and radiochemistry.
Medical subject headings
- Fluorodeoxyglucose F18
- Positron-Emission Tomography